Renaissance Capital’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Renaissance Capital’s Portfolio NARI Stock Details NARI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-15,943	Closed	-$984K	–	87
2023 Q1	$984K	Sell	15,943 -1,710	-10%	-$103K	0.73%	38
2022 Q4	$1.12M	Sell	17,653 -564	-3%	-$40.9K	0.88%	32
2022 Q3	$1.32M	Buy	+18,217	New	+$1.36M	0.85%	28

Other funds holding NARI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Renaissance Capital's NARI Position: Q2 2023 in Review

Renaissance Capital sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2023, closing a stake of 15,943 shares — an estimated $984K sold.

Renaissance Capital first reported a position in NARI in Q3 2022 and held it in 3 quarters. The position peaked at $1.32M in Q3 2022. 250 funds tracked by Wall St. Rank hold NARI as of Q2 2023.

Renaissance Capital reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
Renaissance Capital sold 15,943 Inari Medical, Inc. Common Stock shares in Q2 2023, an estimated $984K.
Renaissance Capital first reported a position in Inari Medical, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
Renaissance Capital's Inari Medical, Inc. Common Stock position peaked at $1.32M in Q3 2022.
250 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2023.

Based on Renaissance Capital's 13F filing for Q2 2023, filed 17 Jul 2023.